Suppl. Figure 6 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

(A) Semi-quantitative evaluation on immunohistochemically stained sections of the frequency of tumor cells expressing the potential T-cell target antigens CRKII, CFL1, NME2, and CNTN1 in astrocytoma (WHO{degree sign}II: n = 10, WHO{degree sign}III: n = 10) and (B) oligodendroglioma (WHO{degree sign}II: n = 10, WHO{degree sign}III: n = 10) tumor tissues.